CARDIOVASCULAR JOURNAL OF AFRICA • Volume 25, No 4, July/August 2014
190
AFRICA
gadolinium-enhanced cardiovascular magnetic resonance.
Circulation
2003;
108
: 54–59.
40. Marcus FI, McKenna WJ, Sherrill D,
et al
. Diagnosis of arrhythmogen-
ic right ventricular cardiomyopathy/dysplasia: proposed modification of
the Task Force criteria.
Circulation
2010;
121
: 1533–1541.
41. Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ.
Cardiovascular magnetic resonance in cardiac amyloidosis.
Circulation
2005;
111
: 186–193.
42. Smedema JP, Snoep G, van Kroonenburgh MP,
et al
. Evaluation of the
accuracy of gadolinium-enhanced cardiovascular magnetic resonance
in the diagnosis of cardiac sarcoidosis.
J Am CollCardiol
2005;
45
:
1683–1690.
43. Patel MR, Cawley PJ, Heitner JF,
et al
. Detection of myocardial damage
in patients with sarcoidosis.
Circulation
2009;
120
: 1969–1977.
44. Abdel-Aty H, Boyé P, Zagrosek A,
et al
. Diagnostic performance of
cardiovascular magnetic resonance in patients with suspected acute
myocarditis: comparison of different approaches.
J Am Coll Cardiol
2005;
45
: 1815–1822.
45. Friedrich MG, Sechtem U, Schulz-Menger J,
et al
. Cardiovascular
magnetic resonance in myocarditis A JACC White Paper.
J Am Coll
Cardiol
2009;
53
: 1475–1487.
46. Lurz P, Eitel I, Adam J,
et al
. Diagnostic performance of CMR imaging
compared with EMB in patients with suspected myocarditis
. J Am Coll
Cardiol Img
2012;
5
: 513–524.
47. Cawley PJ, Maki JH, Otto CM. Cardiovascular magnetic resonance
imaging for valvular heart disease.
Circulation
2009;
119
: 468–478.
48. Hamdan A, Asbach P, Wellnhofer E,
et al
. A prospective study for
comparison of MR and CT imaging for detection of coronary artery
stenosis.
J Am Coll Cardiol Img
2011; 4(1): 50–61.
49. Dirksen MS, Bax JJ, Blom NA,
et al
. Malignant right coronary
artery anomaly detected by magnetic resonance coronary angiography.
Circulation
2002;
106
: 1881–1882.
50. Iles L, Pfluger H, Phrommintikul A,
et al.
Evaluation of diffuse myocar-
dial fibrosis in heart failure with cardiac magnetic resonance contrast
enhanced T1 mapping.
J Am Coll Cardiol
2008;
5
2: 1574–1580.
51. Flett AS, Hayward MP, Ashworth MT,
et al
. Equilibrium contrast
cardiovascular magnetic resonance for the measurement of diffuse
myocardial fibrosis: preliminary validation in humans.
Circulation
2010;
122
: 138–144.
52. Zhao XQ, Dong L, Hatsukami T,
et al
. MR imaging of carotid plaque
composition during lipid-lowering therapy.
J Am Coll Cardiol Img
2011;
4
: 977–986.
